Tezacitabine and Oxaliplatin for the Treatment of Patients With Metastatic Colorectal Cancer
Status:
Terminated
Trial end date:
2004-08-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to determine the best dose of tezacitabine when combined
with oxaliplatin in patients with metastatic colorectal cancer. This study will also evaluate
tumor response to the combination of anti-cancer drugs.